Technology area: Medical Devices & Mechanical Engineering
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Lungpacer Medical Inc. has 3 pending office actions in the Medical Devices & Mechanical Engineering technology area. These 3 pending office actions are handled by 3 distinct examiners. The portfolio is divided between 2 distinct art units, which suggests that two of the examiners may be working within the same technical group while the third is in a different one. Having 3 distinct examiners for 3 actions means each matter has a unique reviewer.
The busiest examiner for this company is MARSH, OWEN LEWIS, who is responsible for 1 busiest examiner pending office action. This 1 busiest examiner pending office action is consistent with the workload of the other 3 distinct examiners. With 3 pending office actions across 2 distinct art units, the company's prosecution is relatively focused but involves multiple perspectives. Practitioners should monitor the 2 distinct art units for varying examination trends that may affect the company's active applications in the medical device field.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MARSH, OWEN LEWIS | 1 | 66.7% | +50.0% |
| GHAND, JENNIFER LEIGH-STEWAR | 1 | 60.5% | +27.8% |
| EDWARDS, PHILIP CHARLES | 1 | 85.0% | +15.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18605386 | SYSTEMS AND METHODS FOR TRANS-ESOPHAGEAL SYMPATHETIC GANGLION RECRUITMENT | GHAND, JENNIFER LEIGH-STEWAR | 3d overdue |
| 17663064 | SYSTEMS AND METHODS FOR SENSING AND STIMULATION | EDWARDS, PHILIP CHARLES | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18605386 | SYSTEMS AND METHODS FOR TRANS-ESOPHAGEAL SYMPATHETIC GANGLION RECRUITMENT | GHAND, JENNIFER LEIGH-STEWAR | 3d overdue |
| 19029261 | TRANSVASCULAR NERVE STIMULATION APPARATUS AND METHODS | MARSH, OWEN LEWIS | — |
| 17663064 | SYSTEMS AND METHODS FOR SENSING AND STIMULATION | EDWARDS, PHILIP CHARLES | — |
| Art Unit | Apps |
|---|---|
| 3796 | 2 |
| 3792 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19029261 | TRANSVASCULAR NERVE STIMULATION APPARATUS AND METHODS | MARSH, OWEN LEWIS | 3796 | §103 | Non-Final OA | — | Pending | Jan 17, 2025 |
| 18605386 | SYSTEMS AND METHODS FOR TRANS-ESOPHAGEAL SYMPATHETIC GANGLION RECRUITMENT | GHAND, JENNIFER LEIGH-STEWAR | 3796 | §102§103§112 | Final Rejection | 3d overdue | Pending | Mar 14, 2024 |
| 17663064 | SYSTEMS AND METHODS FOR SENSING AND STIMULATION | EDWARDS, PHILIP CHARLES | 3792 | §103§112 | Final Rejection | — | Pending | May 12, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialLungpacer Medical Inc. has 3 pending office actions as of October 2026, spread across 2 art units and 3 examiners.
Owen Lewis Marsh has the most, with 1 of Lungpacer Medical Inc.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
